Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Primelink Biotherapeitics(shenzhen) Limited

Clinical trials sponsored by Primelink Biotherapeitics(shenzhen) Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug PLB-002 targets Hard-to-Treat cancers in early trial Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug PLB-002 targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called PLB-002 in about 100 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and understand side effects. PLB-002 is designed to target a protein (Claudin 6) found on some…

Phase 1 • Sponsor: Primelink BioTherapeitics(ShenZhen) Limited • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC